PHARMACOKINETIC PROFILE OF 75 MG CLOPIDOGREL IN PLASMA OF INDONESIAN HEALTHY SUBJECTS BY ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY

Authors

  • Yahdiana Harahap Department of Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.
  • Ganesya Rita Putri Department of Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.
  • Herman Suryadi Department of Bioavailability/Bioequivalence Laboratory, Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.

DOI:

https://doi.org/10.22159/ijap.2018.v10s1.73

Keywords:

Clopidogrel, Ultra-high-performance liquid chromatography-tandem mass spectrometry, Plasma, Pharmacokinetic profile, Bioanalysis

Abstract

Objective: This study aimed to determine clopidogrel in plasma to obtain its pharmacokinetic profile using ultra-high-performance liquid
chromatography-tandem mass spectrometry (UPLC-MS/MS).
Methods: Clopidogrel analysis was performed in vivo by UPLC-MS/MS using validated methods. Subjects received 75 mg clopidogrel, and plasma
samples were collected at 14 time points after 0 baseline (pre-dose): 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2, 3, 4, 8, 12, 18, and 24 h.
Results: A linear calibration curve was produced in the range of 20–5.000 pg/mL. This method fulfills the criteria for validation according to the
European Medicines Agency guidelines. The obtained pharmacokinetic profile of clopidogrel was as follows: Maximum concentration=1.146 ng/mL,
time at maximum concentration (tmax)=1 h, half-life (t½)=7.01 h, area under curve (AUC)0−t=7.420 ng h/mL, and AUC0−t=8.111 ng h/mL.
Conclusion: Clopidogrel analysis using a UPLC/MS-MS system with liquid-liquid extraction method was successfully conducted using plasma samples
from three healthy subjects who administered 75 mg of clopidogrel tablet.

Downloads

Download data is not yet available.

References

European Medicines Agency. Assessment Report for Clopidogrel Teva.

London: European Medicines Agency; 2009.

Indonesia National Agency of Food and Drug Control. Regulation

from Head of Indonesia National Agency of Food and Drug Control

No. HK.03.1.23.12.11.10217 about Drugs Obligate Equivalence Test.

Jakarta; 2011. [In Indonesian]

Alesci J, Victorino A. Clopidogrel. New York: Nova Biomedical/Nova

Science; 2014.

Bhargav K, Venkata SB, Venkata SK, Himaja G, Samuel GG,

Bhaskar RK. Pharmacokinetic drug interaction between clopidogrel

and esomeprazole in adult healthy male volunteers. Asian J Pharm Clin

Res 2017;10:336-41.

Gurupadayya BM, Sama S. Bio-analytical determination of clopidogrel

and pantoprazole by RP-HPLC method in rat plasma: Application to

drug interaction study. Asian J Pharm Clin Res 2014;7:10-3.

Reddy DN. Design, development and characterization of clopidogrel

bisulfate transdermal drug delivery system. Asian J Pharm Clin Res

;8:277-80.

Harahap Y. Role of Bioanalysis in Assuring Drug Quality and Increasing

Quality of Patient Life. Depok: UI Press; 2010.

KarazÌniewicz-Åada M, Danielak D, Teżyk A, Żaba C, Tuffal G,

Główka F. HPLC–MS/MS method for the simultaneous determination

of clopidogrel, its carboxylic acid metabolite and derivatized isomers of

thiol metabolite in clinical samples. J Chromatogr B 2012;911:105-12.

Divi KR, Jayaveera KN, Naidu YK, Reddy MK. Development and

validation of high-throughput liquid chromatography–tandem mass

spectrometric method for simultaneous quantification of clopidogrel

and its metabolite in human plasma. J Chromatogr B 2010;878:502-8.

Zou JJ, Tan J, Fan HW, Chen SL. Bioequivalence study of clopidogrel

mg tablets in healthy male volunteers. J Bioequiv Bioavailab

;4:6-9.

European Medicines Agency. Guideline on Bioanalytical Method

Validation. London: European Medicines Agency; 2011.

Robinson A, Hillis J, Neal C, Leary AC. The validation of a

bioanalytical method for the determination of clopidogrel in human

plasma. J Chromatogr B 2007;848:344-54.

Published

20-12-2018

How to Cite

Harahap, Y., Putri, G. R., & Suryadi, H. (2018). PHARMACOKINETIC PROFILE OF 75 MG CLOPIDOGREL IN PLASMA OF INDONESIAN HEALTHY SUBJECTS BY ULTRA HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY. International Journal of Applied Pharmaceutics, 10(1), 331–334. https://doi.org/10.22159/ijap.2018.v10s1.73

Issue

Section

Original Article(s)

Most read articles by the same author(s)

1 2 3 4 > >>